(Q33208807)

23 July 2017

Neuroleptic malignant syndrome in a child treated with an atypical antipsychotic (English)

1 reference

neuroleptic malignant syndrome

23 July 2017

1 reference

5

Matitiahu Berkovitch

1 reference

23 July 2017

Ibrahim Abu-Kishk

1

1 reference

23 July 2017

Michal Toledano

series ordinal

2

1 reference

23 July 2017

Ahuva Reis

series ordinal

3

1 reference

23 July 2017

David Daniel

series ordinal

4

1 reference

23 July 2017

1 January 2004

1 reference

Journal of Toxicology: Clinical Toxicology

23 July 2017

1 reference

23 July 2017

42

1 reference

23 July 2017

6

1 reference

23 July 2017

921-925

1 reference

Neuroleptic malignant syndrome in a patient with Wilson's disease

23 July 2017

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200035214

Risk factors for neuroleptic malignant syndrome. A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200035214

Neuroleptic malignant syndrome after clozapine plus carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200035214

Clozapine-induced neuroleptic malignant syndrome: review and report of new cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200035214

Neuroleptic malignant syndrome associated with olanzapine therapy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200035214

Olanzapine usage associated with neuroleptic malignant syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200035214

Neuroleptic malignant syndrome in an adolescent receiving olanzapine-lithium combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200035214

ECT treatment of malignant catatonia/NMS in an adolescent: a useful lesson in delayed diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200035214

The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200035214

Neuroleptic malignant syndrome: review and analysis of 115 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200035214

Residual catatonic state following neuroleptic malignant syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200035214

21 January 2018

Identifiers

DOI

10.1081/CLT-200035214

1 reference

23 July 2017

1 reference